Diverse regulation of protein function by O-GlcNAc: A nuclear and cytoplasmic carbohydrate post-translational modification

Current Opinion in Chemical Biology

Volumn 6, Issue 6, 2002, Pages 851-857

  Vosseller, Keith ^a   Sakabe, Kaoru ^a   Wells, Lance ^a   Hart, Gerald W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; NUCLEAR PROTEIN; SERINE DERIVATIVE; THREONINE; GLUCOSE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE;

BIOCHEMISTRY; CELL LEVEL; CELL NUCLEUS; CYTOPLASM; GLYCOSYLATION; NONHUMAN; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; HUMAN; METABOLISM; PHOSPHORYLATION;

EUKARYOTA;

ACETYLGLUCOSAMINE; ANIMALS; CELL NUCLEUS; CYTOPLASM; GLUCOSE; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 0036898933     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00384-8     Document Type: Article

References (63)

1. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
2. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:2000;1176-1179.
3. McBride A.E., Silver P.A. State of the Arg: protein methylation at arginine comes of age. Cell. 106:2001;5-8.
4. Hart G. Dynamic O-glycosylation of nuclear and cytosolic proteins. Annu Rev Biochem. 66:1997;315-335.
5. Wells L., Vosseller K., Hart G.W. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 291:2001;2376-2378. This review discusses the characteristics of O-GlcNAc that make it more analogous to regulatory post-translational modifications such as phosphate than complex carbohydrates.
6. Hanover J.A. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J. 15:2001;1865-1876. This review describes how the complex balance between enzymatic phosphorylation/dephosphorylation and O-GlcNAc addition and removal are likely to operate in signaling systems in mammalian cells.
7. Kreppel L.K., Blomberg M.A., Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem. 272:1997;9308-9315.
8. Lubas W.A., Frank D.W., Krause M., Hanover J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem. 272:1997;9316-9324.
9. Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem. 276:2001;9838-9845.
10. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA. 97:2000;5735-5739. Knockout of the gene encoding OGT is lethal in embryonic stem cells, demonstrating the fundamental requirement for O-GlcNAc in mammalian cells.
11. Kelly W.G., Hart G.W. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell. 57:1989;243-251.
12. Lefebvre T., Planque N., Leleu D., Bailly M., Caillet-Boudin M.L., Saule S., Michalski J.C. O-glycosylation of the nuclear forms of Pax-6 products in quail neuroretina cells. J Cell Biochem. 85:2002;208-218.
13. Comer F.I., Hart G.W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry. 40:2001;7845-7852.
14. Kamemura K., Hayes B.K., Comer F.I., Hart G.W. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: alternative glycosylation/phosphorylation of THR-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem. 277:2002;19229-19235.
15. Roos M.D., Su K., Baker J.R., Kudlow J.E. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol. 17:1997;6472-6480.
16. Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., Kudlow J.E. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci USA. 98:2001;6611-6616. Using Sp1-dependent reporter constructs in mammalian cells, this is an example in vivo of O-GlcNAc on Sp1 blocking the ability of this transcription factor to activate transcription.
17. Yang X., Zhang F., Kudlow J.E. Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A. Coupling protein O-GlcNAcylation to transcriptional repression. Cell. 110:2002;69-80. This study functionally links O-GlcNAc with gene silencing, showing that localization of OGT to transcriptional repression complexes through interaction with mSin3A is required for full inhibition in a luciferase reporter assay.
18. James L.R., Tang D., Ingram A., Ly H., Thai K., Cai L., Scholey J.W. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation. Diabetes. 51:2002;1146-1156.
19. Fiordaliso F., Leri A., Cesselli D., Limana F., Safai B., Nadal-Ginard B., Anversa P., Kajstura J. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes. 50:2001;2363-2375.
20. Huet G., Kim I., de Bolos C., Lo-Guidice J.M., Moreau O., Hemon B., Richet C., Delannoy P., Real F.X., Degand P. Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. J Cell Sci. 108:1995;1275-1285.
21. Delannoy P., Kim I., Emery N., De Bolos C., Verbert A., Degand P., Huet G. Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconj J. 13:1996;717-726.
22. Cheng X., Hart G.W. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J Biol Chem. 276:2001;10570-10575.
23. Han I., Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol. 17:1997;2550-2558.
24. Wenger R.H. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16:2002;1151-1162.
25. Marshall S., Bacote V., Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem. 266:1991;4706-4712.
26. McClain D.A. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications. 16:2002;72-80.
27. Boehmelt G., Wakeham A., Elia A., Sasaki T., Plyte S., Potter J., Yang Y., Tsang E., Ruland J., Iscove N.N., et al. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. EMBO J. 19:2000;5092-5104. This study highlights the unique responsiveness of OGT to UDP-GlcNAc levels in the cell, and strongly correlates dynamic O-GlcNAcylation with proliferative and apoptotic responses.
28. Kreppel L.K., Hart G.W. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J Biol Chem. 274:1999;32015-32022.
29. Yki-Jarvinen H., Virkamaki A., Daniels M.C., McClain D., Gottschalk W.K. Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo. Metabolism. 47:1998;449-455.
30. Federici M., Menghini R., Mauriello A., Hribal M.L., Ferrelli F., Lauro D., Sbraccia P., Spagnoli L.G., Sesti G., Lauro R. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation. 106:2002;466-472.
31. Vosseller K., Wells L., Lane M.D., Hart G.W. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA. 99:2002;5313-5318. This study demonstrates a causal role for elevated O-GlcNAc in the development of insulin resistance in adipocytes, by specifically attenuating insulin signaling through inhibition O-GlcNAcase.
32. Buse M.G., Robinson K.A., Marshall B.A., Hresko R.C., Mueckler M.M. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. Am J Physiol Endocrinol Metab. 283:2002;E241-E250.
33. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., Hanover J.A. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA. 22:2002;22. This study provides strong genetic evidence of a role for elevated O-GlcNAc in the development of insulin resistance, through targeted transgenic overexpression of OGT in muscle and adipose tissue of mice.
34. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 108:2001;1341-1348.
35. Hawkins M., Barzilai N., Liu R., Hu M., Chen W., Rossetti L. Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest. 99:1997;2173-2182.
36. Wells LV, Vosseller K, Hart GW: A role for O-GlcNAc as a nutrient sensor and mediator of insulin resistance. Cell Mol Life Sci 2002, in press.
37. Liu K., Paterson A.J., Chin E., Kudlow J.E. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci USA. 97:2000;2820-2825.
38. Hanover J.A., Lai Z., Lee G., Lubas W.A., Sato S.M. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells. Arch Biochem Biophys. 362:1999;38-45.
39. O'Brien B.A., Harmon B.V., Cameron D.P., Allan D.J. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol. 178:1996;176-181.
40. Konrad R.J., Mikolaenko I., Tolar J.F., Liu K., Kudlow J.E. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J. 356:2001;31-41.
41. Kaneto H., Xu G., Song K.H., Suzuma K., Bonner-Weir S., Sharma A., Weir G.C. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem. 276:2001;31099-31104.
42. Gao Y., Parker G.J., Hart G.W. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells. Arch Biochem Biophys. 383:2000;296-302.
43. Nakamura M., Barber A.J., Antonetti D.A., LaNoue K.F., Robinson K.A., Buse M.G., Gardner T.W. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem. 276:2001;43748-43755.
44. Zhu W., Leber B., Andrews D.W. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J. 20:2001;5999-6007.
45. Haltiwanger R.S., Grove K., Philipsberg G.A. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J Biol Chem. 273:1998;3611-3617.
46. Wells L., Gao Y., Mahoney J.A., Vosseller K., Chen C., Rosen A., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem. 277:2002;1755-1761.
47. Pawson T., Gish G.D., Nash P. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11:2001;504-511.
48. Yaffe M.B. How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513:2002;53-57.
49. Glithero A., Tormo J., Haurum J.S., Arsequell G., Valencia G., Edwards J., Springer S., Townsend A., Pao Y.L., Wormald M., et al. Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity. Immunity. 10:1999;63-74.
50. Lefebvre T., Cieniewski C., Lemoine J., Guerardel Y., Leroy Y., Zanetta J.P., Michalski J.C. Identification of N-acetyl-D-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins. Biochem J. 360:2001;179-188.
51. Messenger M.M., Saulnier R.B., Gilchrist A.D., Diamond P., Gorbsky G.J., Litchfield D.W. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions. J Biol Chem. 277:2002;23054-23064.
52. Akimoto Y., Kreppel L.K., Hirano H., Hart G.W. Hyperglycemia and the O-GlcNAc transferase in rat aortic smooth muscle cells: elevated expression and altered patterns of O-GlcNAcylation. Arch Biochem Biophys. 389:2001;166-175.
53. Konrad R.J., Janowski K.M., Kudlow J.E. Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets. Biochem Biophys Res Commun. 267:2000;26-32.
54. Konrad R.J., Tolar J.F., Hale J.E., Knierman M.D., Becker G.W., Kudlow J.E. Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase. Biochem Biophys Res Commun. 288:2001;1136-1140.
55. Hart G.W., Kreppel L.K., Comer F.I., Arnold C.S., Snow D.M., Ye Z., Cheng X., DellaManna D., Caine D.S., Earles B.J., et al. O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization. Glycobiology. 6:1996;711-716.
56. Slawson C., Pidala J., Potter R. Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta. 1537:2001;147-157.
57. Dong D.L., Hart G.W. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem. 269:1994;19321-19330.
58. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., Tatsumi H., Yamasaki Y., Kamada T., Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes. 44:1995;733-738.
59. Konrad R.J., Zhang F., Hale J.E., Knierman M.D., Becker G.W., Kudlow J.E. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun. 293:2002;207-212.
60. Chalkley R.J., Burlingame A.L. Identification of GlcNAcylation sites of peptides and alpha-crystallin using Q-TOF mass spectrometry. J Am Soc Mass Spectrom. 12:2001;1106-1113.
61. Goshe M.B., Veenstra T.D., Panisko E.A., Conrads T.P., Angell N.H., Smith R.D. Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. Anal Chem. 74:2002;607-616.
62. Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW: Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol Cell Proteomics 2002, e-pub ahead of print: 10.1074/mcp.M200048-MCP200. This paper describes a proteomic approach for mapping O-GlcNAc and O-phosphate sites. Importantly, it documents the need for phosphorylation researchers to carefully distinguish between the two modifications in their analysis.
63. Comer F.I., Vosseller K., Wells L., Accavitti M.A., Hart G.W. Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem. 293:2001;169-177. This paper describes the development of an improved general anti-O-GlcNAc antibody, which will be a valuable tool in the study of this modification.